GST Collections Above Rs 2 Trillion For Second Straight Month
Gross GST collections remained above the Rs 2 trillion mark for the second month in a row, rising 16.4 per cent in May to over Rs 2.01 lakh crore.
Goods and Services Tax (GST) collection had touched a record high of Rs 2.37 lakh crore in April. In May, 2024, the mop up was Rs 1,72,739 crore.
In May, 2025, gross revenues from domestic transactions rose 13.7 per cent to about Rs 1.50 lakh crore, while GST revenue from imports grew 25.2 per cent to Rs 51,266 crore. Total gross GST revenues stood at Rs 2,01,050 crore in May, 2025.
Gross Central GST revenues stood at Rs 35,434 crore, State GST revenues at Rs 43,902 crore and Integrated GST at about Rs 1.09 lakh crore. Revenues from Cess was at Rs 12,879 crore.
Total refunds issued during the month dipped 4 per cent to Rs 27,210 crore.
Net GST mop-up in May stood at about Rs 1.74 lakh crore, a 20.4 per cent year-on-year growth.
Deloitte India Partner M S Mani said the wide variations in the growth of GST collections across states require a thorough analysis across the sectors that are important in each state.
While large states like Maharashtra, West Bengal, Karnataka and Tamil Nadu have reported collection increases of 17 per cent to 25 per cent, similar large states like Gujarat, Andhra Pradesh and Telangana have shown increases of up to 6 per cent.
Some states like Madhya Pradesh, Haryana, Punjab and Rajasthan have shown median increases of 10 per cent.
"Hence, the average growth across the country does not appear to be uniformly reflected across states possibly due to sectoral or seasonal factors which require a deeper data based analysis," Mani said.
Price Waterhouse & Co LLP Partner Pratik Jain said 16 per cent growth in GST collections in the month shows a renewed upward momentum after a few months of growth in the range of 11 to 12 per cent.
"If the growth continues in this range for the next couple of months, it might provide the cushion for the government to look at rate rationalization on which a lot of work has already been done," Jain said.
EY India Tax Partner Saurabh Agarwal said looking ahead, we might see similar GST collection numbers with slight increases in June because of ongoing geopolitical tensions across the globe.
Tax Connect Advisory Services LLP Partner Vivek Jalan said with an approx 10 per cent growth in domestic GST revenue and 73 per cent growth in import GST revenues, it is very clear that this month's growth in GST revenue is import driven rather than domestic consumption driven.
"This coupled with the fact that exports refunds are not growing correspondingly, reflect the fact that import growth far exceeds export growth," Jalan added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
27 minutes ago
- Economic Times
IndiGo profit falls sharply on geopolitical tension, Air India crash
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads India's largest airline IndiGo reported a sharp 20% fall in profit as air travel was impacted due to a conflict between India and Pakistan followed by weak travel sentiment after the crash of an Air India aircraft in airline, which has 60% share of India's domestic market, posted a profit of Rs 2,176.3 crore for the April–June period, down 20% from Rs 2,728.8 crore a year ago despite revenue being up by 4.73% at Rs 20,496.30 briefly restricting flights from 32 airports in airports on the north and western border in May amid border skirmishes with Pakistan following a terrorist attack in April.'The June quarter was shaped by significant external challenges that created headwinds for the entire aviation sector. Despite these industry wide disruptions, we reported a net profit margin of around 11% for the quarter ended June 2025,' Pieter Elbers, CEO of indigo a metric for profitability for airlines also dropped by 5% as the airline had to reduce fares to fill aircraft which dropped by a little over 2%.The airline though gave optimistic note and outlined plans for expansion. Elbers said the airline has begun long-haul services to Europe, launching flights to Amsterdam and Manchester in early July. Given strong demand, IndiGo will double its frequency to Amsterdam and add a fourth weekly flight to Manchester. A reciprocal codeshare with KLM will also expand the airline's reach across Europe.'We remain firm on our full year capacity guidance of early double digit capacity addition. While we have taken a number of proactive steps as part of our plan to align capacity with the demand, we are using the downtime to conduct structural inspections on some aircrafts and implementing fleet upgrades, ensuring the fleet is fully prepared for the seasonally strong third quarter,' Chief Financial Officer Gaurav Negi said in a post-results call with debuting on the Delhi–Mumbai route late last year, IndiGo's business class product (called Stretch) has now been extended to flights to Bangkok and will soon launch on routes to Singapore and Dubai. Elbers said the market response has been encouraging, with load factors improving the domestic front, IndiGo recently began operations from Hindon airport in Delhi and is looking to expand its network further.
The Hindu
30 minutes ago
- The Hindu
Hyundai Motor India Q1 net slides 8% to ₹1,369 crore
Hyundai Motor India Ltd. (HMIL) for the first quarter ended June 30, 2025 reported 8% fall in consolidated net profit at 1,369 crore. The company's revenue during the quarter also dropped 5.36% to Rs.16,413 crore from Rs.17,344 crore a year ago. The company witnessed accelerated exports growth and volumes increased 13% on YoY basis, while domestic growth remained subdued, amid macro challenges, the company said in a filing. Unsoo Kim, Managing Director, HMIL said, 'We continued our stated strategy of 'Quality of Growth' in the first quarter of FY26 with balance between domestic & exports, market share and profitability.' 'This strategy helped us to sustain strong EBITDA margin of 13.3% during the quarter, despite tough macro-economic environment,' he said. 'Moving forward, we anticipate gradual recovery in domestic demand sentiments, driven by onset of monsoon & festive season coupled with government policy measures, while on the exports front, we are confident to maintain a positive momentum, in line with our growth commitments,' he added.
&w=3840&q=100)
Business Standard
30 minutes ago
- Business Standard
JB Pharma Q1 profit up 14%, revenue up 9% on domestic segment gains
JB Chemicals and Pharmaceuticals posted a 14.4 per cent increase in its consolidated net profit at Rs 202 crore for the first quarter of the financial year (Q1FY26). Revenue from operations also rose by 8.9 per cent to Rs 1,093 crore. Sequentially, net profit increased by 38 per cent, with revenue also growing by 15 per cent. Nikhil Chopra, chief executive officer and wholetime director, JB Pharma, stated: 'The domestic business recorded approximately 14 per cent value growth. This was driven by acute and chronic segments, including our ophthalmology portfolio. Our major brands and their franchises are also performing well. The CDMO business momentum is likely to sustain in the coming quarters.' Going forward, the company will focus on increasing topline growth along with optimisation of costs and organisational efficiencies. It expects the domestic and CDMO segments to lead growth and profitability. The company claims it is one of the fastest-growing domestic pharmaceutical companies among the top 25 organisations, as per IQVIA MAT June 2025 data. JB Pharma's ophthalmology portfolio delivered robust 19 per cent growth, reaching Rs 57 crore in Q1FY26. The Razel franchise crossed Rs 100 crore in MAT June 2025, up from Rs 69 crore in MAT June 2023, while Azmarda sales rose to Rs 75 crore from Rs 69 crore in MAT June 2024. International business revenue grew 2 per cent year-on-year (Y-o-Y) to Rs 416 crore, compared to Rs 409 crore. However, the international formulations segment declined 2 per cent to Rs 283 crore. While branded generics exports grew during the quarter, markets such as Russia, the US and South Africa remained flat or marginally declined. The CDMO business posted an 8 per cent increase to Rs 115 crore, with strong momentum expected to continue. The active pharmaceutical ingredient (API) segment reported 38 per cent Y-o-Y growth, rising to Rs 18 crore from Rs 13 crore. The results were announced after market hours. JB's share fell by 1.08 per cent, ending the day's trade at Rs 1,782.90 apiece on the BSE.
